GO:0060972

BP

left/right pattern formation

The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.

CITED2

GO:0060973

BP

cell migration involved in heart development

The orderly movement of a cell from one site to another that will contribute to the progression of the heart over time, from its initial formation, to the mature organ.

BVES, NDRG4

GO:0060976

BP

coronary vasculature development

The process whose specific outcome is the progression of the blood vessels of the heart over time, from its formation to the mature structure.

SMAD6, BMP4, VEGFB, NDST1, AP2B1, LRP2, PTK7, LTBP1, TAB1, PCSK5, PRICKLE1, DCTN5, ADAMTS6, SUFU, PLXND1

GO:0060978

BP

angiogenesis involved in coronary vascular morphogenesis

Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels.

NRP1, TGFBR1

GO:0060979

BP

vasculogenesis involved in coronary vascular morphogenesis

The differentiation of endothelial cells from progenitor cells that contributes to blood vessel development in the heart, and the de novo formation of blood vessels and tubes.

NOTCH1, TGFBR3

GO:0060981

BP

cell migration involved in coronary angiogenesis

The orderly movement of a cell from one site to another that will contribute to the formation of new blood vessels in the heart from pre-existing blood vessels.

PDGFRB

GO:0060982

BP

coronary artery morphogenesis

The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.

NRP1, TBX1, VEGFA, TGFBR1, NOTCH1

GO:0060988

BP

lipid tube assembly

The aggregation, arrangement and bonding together of a set of macromolecules to form a macromolecular complex that contains a tube of lipid surrounded by a protein coat involved in membrane shaping of vesicle membranes as they fuse or undergo fission.

BIN1, SNX9

GO:0060992

BP

response to fungicide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fungicide stimulus. Fungicides are chemicals used to kill fungi.

KDM1A, SRD5A1, STAR, KDM5B

GO:0060993

BP

kidney morphogenesis

Morphogenesis of a kidney. A kidney is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.

PRKX, SOX4, NPHP3

GO:0060996

BP

dendritic spine development

The process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.

UBA6, ACSL4, ARF4, EPHB2, EPHB1, PAK2, SLC9A6

GO:0060997

BP

dendritic spine morphogenesis

The process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.

PAK3, EPHB2, EPHB1, PTEN, DLG4, HDAC6

GO:0060998

BP

regulation of dendritic spine development

Any process that modulates the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.

MEF2C, FMR1, SDK1, CPEB3

GO:0060999

BP

positive regulation of dendritic spine development

Any process that increases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.

APOE, PSEN1, ARF1, NRG1, FMR1, CAMK1, NLGN1, CPEB3, LLPH

GO:0061000

BP

negative regulation of dendritic spine development

Any process that decreases the rate, frequency, or extent of dendritic spine development, the process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure.

HDAC2, PLK2, ASAP1

GO:0061001

BP

regulation of dendritic spine morphogenesis

Any process that modulates the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.

CFL1, EPHA4, CDK5, PDLIM5

GO:0061002

BP

negative regulation of dendritic spine morphogenesis

Any process that decreases the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.

EFNA1, PTEN, NLGN1

GO:0061003

BP

positive regulation of dendritic spine morphogenesis

Any process that modulates the rate, frequency, or extent of dendritic spine morphogenesis, the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.

PAK3, ITPKA, TIAM1, CAPRIN1

GO:0061005

BP

cell differentiation involved in kidney development

The process in which relatively unspecialized cells acquire specialized structural and/or functional features that characterize the cells of the kidney as it progresses from its formation to the mature state.

GLI3, PTCH1

GO:0061009

BP

common bile duct development

The progression of the common bile duct over time, from its formation to the mature structure. The common bile duct is formed from the joining of the common hepatic duct running from the liver, and the cystic duct running from the gall bladder. The common bile duct transports bile from the liver and gall bladder to the intestine.

HES1, SOX17, MKS1

GO:0061010

BP

gall bladder development

The progression of the gall bladder over time, from its initial formation to the mature structure. The gall bladder is a cavitated organ that stores bile.

HHEX, NIPBL, SOX17

GO:0061011

BP

hepatic duct development

The progression of the hepatic duct over time, from its formation to the mature structure. The hepatic duct is the duct that leads from the liver to the common bile duct.

HHEX

GO:0061014

BP

positive regulation of mRNA catabolic process

Any process that increases the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.

CNOT1, HNRNPR, PNPT1, KHSRP, CNOT7

GO:0061017

BP

hepatoblast differentiation

The process in which a relatively unspecialized cell acquires specialized features of a hepatoblast. A hepatoblast is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into hepatocytes and cholangiocytes.

HHEX

GO:0061024

BP

membrane organization

A process which results in the assembly, arrangement of constituent parts, or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins.

GNPAT, TBC1D4, PMP2, RALA, YWHAB, SFN, PRKCI, YWHAE, YWHAZ, YWHAH, CLN3, DHCR24, SGCB, CCDC88A, LPCAT2, SGCD, SGCZ, CHP1, LNPEP

GO:0061025

BP

membrane fusion

The membrane organization process that joins two lipid bilayers to form a single membrane.

SNAP23, GOSR2, STX11, SNAP29, VAMP2, RABEP1, VAMP3, HACE1, CHP1, NAPB, BET1L, VAPA, VTI1B, BLOC1S6, NSFL1C

GO:0061026

BP

cardiac muscle tissue regeneration

The regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.

ERBB4

GO:0061028

BP

establishment of endothelial barrier

The establishment of a barrier between endothelial cell layers, such as those in the brain, lung or intestine, to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition.

ICAM1, EZR, RDX, F2RL1, RAP1A, PDE4D, RAPGEF1, MYADM

GO:0061029

BP

eyelid development in camera-type eye

The progression of the eyelid in a camera-type eye from its formation to the mature state. The eyelid is a membranous cover that helps protect and lubricate the eye.

EGFR, JUN, INHBA, SOS1, HDAC1, TWIST1, HDAC2

GO:0061030

BP

epithelial cell differentiation involved in mammary gland alveolus development

The process in which a relatively unspecialized epithelial cell becomes a more specialized epithelial cell of the mammary gland alveolus.

ID2, HIF1A

GO:0061031

BP

endodermal digestive tract morphogenesis

The process in which the anatomical structures of the endodermal digestive tract are generated and organized. The endodermal digestive tract includes those portions of the digestive tract that are derived from endoderm.

ID2, PITX2, SOX17

GO:0061032

BP

visceral serous pericardium development

The progression of the visceral serous pericardium from its formation to the mature structure. The visceral serous pericardium is the inner layer of the pericardium.

WT1

GO:0061033

BP

secretion by lung epithelial cell involved in lung growth

The controlled release of liquid by a lung epithelial cell that contributes to an increase in size of the lung as part of its development.

FGF7

GO:0061034

BP

olfactory bulb mitral cell layer development

The progression of the olfactory bulb mitral cell layer over time from its initial formation until its mature state. The mitral cell layer is composed of pyramidal neurons whose cell bodies are located between the granule cell layer and the plexiform layer.

OGDH

GO:0061035

BP

regulation of cartilage development

Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.

TGFB1

GO:0061036

BP

positive regulation of cartilage development

Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.

CYR61, BMP10, BMP2, BMP4, BMP1, SOX6, WNT5A, SOX9, ZBTB16, BMPR2, SMAD1

GO:0061037

BP

negative regulation of cartilage development

Any process that decreases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.

LEP, TGFB2

GO:0061038

BP

uterus morphogenesis

The process in which anatomical structures of the uterus are generated and organized.

NIPBL, KDM5B

GO:0061040

BP

female gonad morphogenesis

The process in which a female gonad is generated and organized.

SMAD4

GO:0061041

BP

regulation of wound healing

Any process that modulates the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.

PLAU, SRSF6, TNFRSF12A

GO:0061042

BP

vascular wound healing

Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.

MCAM, ADIPOR2, NDNF, HPSE

GO:0061043

BP

regulation of vascular wound healing

Any process that modulates the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.

TNFAIP3

GO:0061044

BP

negative regulation of vascular wound healing

Any process that decreases the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.

SERPINE1

GO:0061045

BP

negative regulation of wound healing

Any process that decreases the rate, frequency, or extent of the series of events that restore integrity to a damaged tissue, following an injury.

CASK, APCS, HMGCR, SERPINE1, FGF2, GJA1, SMAD3, WFDC1

GO:0061046

BP

regulation of branching involved in lung morphogenesis

Any process that modulates the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.

SOX9

GO:0061047

BP

positive regulation of branching involved in lung morphogenesis

Any process that modulates the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.

BMP4

GO:0061048

BP

negative regulation of branching involved in lung morphogenesis

Any process that decreases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.

TNF

GO:0061049

BP

cell growth involved in cardiac muscle cell development

The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.

SORBS2, AGT, GATA4, AGTR2, CAMK2D, PDLIM5

GO:0061051

BP

positive regulation of cell growth involved in cardiac muscle cell development

Any process that increases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.

IGF1, EDN1, HAMP, AKAP6

GO:0061052

BP

negative regulation of cell growth involved in cardiac muscle cell development

Any process that decreases the rate, frequency, or extent of the growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state.

G6PD

GO:0061053

BP

somite development

The progression of a somite from its initial formation to the mature structure. Somites are mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.

MTHFD1, MEOX1, PPP2R3A, PTCH1, RBBP6

GO:0061056

BP

sclerotome development

The progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra.

MEOX1

GO:0061061

BP

muscle structure development

The progression of a muscle structure over time, from its formation to its mature state. Muscle structures are contractile cells, tissues or organs that are found in multicellular organisms.

CAPN3, RNF165

GO:0061072

BP

iris morphogenesis

The process in which the iris is generated and organized. The iris is an anatomical structure in the eye whose opening forms the pupil. The iris is responsible for controlling the diameter and size of the pupil and the amount of light reaching the retina.

WNT2, HIF1A, WNT2B, PITX2, HIPK2

GO:0061073

BP

ciliary body morphogenesis

The process in which the ciliary body generated and organized. The ciliary body is the circumferential tissue inside the eye composed of the ciliary muscle and ciliary processes.

JAG1

GO:0061074

BP

regulation of neural retina development

Any process that modulates the rate, frequency, or extent of neural retina development, the progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells.

DLL4

GO:0061077

BP

chaperone-mediated protein folding

The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone.

TOR1A, CRTAP, CLU, PDIA4, PPIB, FKBP2, CALR, CANX, FKBP3, FKBP4, PPID, FKBP5, FKBP10, FKBP14, FKBP11, CHORDC1, FKBP7

GO:0061078

BP

positive regulation of prostaglandin secretion involved in immune response

Any process that activates or increases the frequency, rate or extent of the regulated release of a prostaglandin from a cell and contributes to the immune response.

MIF

GO:0061081

BP

positive regulation of myeloid leukocyte cytokine production involved in immune response

Any process that modulates the rate, frequency, or extent of the production of a cytokine that contributes to the immune response.

MIF

GO:0061084

BP

negative regulation of protein refolding

Any process that decreases the rate, frequency, or extent of protein refolding. Protein refolding is the process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones.

PDCL, BAG5

GO:0061086

BP

negative regulation of histone H3-K27 methylation

Any process that decreases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.

H2AFY, SUPT6H, MTF2

GO:0061087

BP

positive regulation of histone H3-K27 methylation

Any process that increases the rate, frequency, or extent of histone H3-K27 methylation. Histone H3-K27 methylation is the modification of histone H3 by addition of a methyl group to lysine at position 27 of the histone.

OGT, PHF19, MTF2

GO:0061088

BP

regulation of sequestering of zinc ion

Any process that modulates the rate, frequency, or extent of sequestering of zinc ion. Sequestering of zinc ion is the process of binding or confining zinc ions such that they are separated from other components of a biological system.

AP3D1, SLC30A8, SLC30A1

GO:0061097

BP

regulation of protein tyrosine kinase activity

Any process that modulates the rate, frequency, or extent of protein tyrosine kinase activity.

RAP2B

GO:0061098

BP

positive regulation of protein tyrosine kinase activity

Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.

GREM1, AGT, PDGFB, CSF1R, ACE, CCL5, ERBB3, CD24, PAK2, UNC119, GAS6, FAM150B, ABI1, AFAP1L2, HSPH1, GPRC5B, GHRL

GO:0061099

BP

negative regulation of protein tyrosine kinase activity

Any process that decreases the rate, frequency, or extent of protein tyrosine kinase activity.

SH3BP5, PTPN2, RACK1, CAV1, HYAL2, SH3BP5L

GO:0061100

BP

lung neuroendocrine cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a neuroendocrine cell of the lung epithelium.

ASCL1

GO:0061101

BP

neuroendocrine cell differentiation

The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a neuroendocrine cell. A neuroendocrine cell is a cell that receives input form a neuron which controls the secretion of an endocrine substance.

BCCIP

GO:0061102

BP

stomach neuroendocrine cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a neuroendocrine cell of the stomach epithelium.

ASCL1

GO:0061103

BP

carotid body glomus cell differentiation

The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a glomus cell of the carotid body. The carotid body is a specialized chemosensory organ that helps respond to hypoxia.

ASCL1

GO:0061104

BP

adrenal chromaffin cell differentiation

The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of an adrenal chromaffin cell. An adrenal chromaffin cell is a neuroendocrine cell that stores epinephrine secretory vesicles.

ASCL1, INSM1

GO:0061106

BP

negative regulation of stomach neuroendocrine cell differentiation

Any process that decreases the rate, frequency or extent of the differentiation of a neuroendocrine cell in the stomach.

HES1

GO:0061108

BP

seminal vesicle epithelium development

The progression of the seminal vesicle epithelium over time, from its formation to the mature structure.

SERPINE2

GO:0061113

BP

pancreas morphogenesis

Morphogenesis of the pancreas. Morphogenesis is the process in which anatomical structures are generated and organized.

NR5A2

GO:0061114

BP

branching involved in pancreas morphogenesis

The process in which the branches of the pancreas are generated and organized.

PROX1

GO:0061136

BP

regulation of proteasomal protein catabolic process

Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.

GPX1, PRKACA, PSME3, TMF1, PKD1, RHBDF1, PINK1, NUDT15, BTRC, UCHL5

GO:0061138

BP

morphogenesis of a branching epithelium

The process in which the anatomical structures of a branched epithelium are generated and organized.

SOX9, SOX8

GO:0061141

BP

lung ciliated cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a lung ciliated cell. A lung ciliated cell is a specialized lung epithelial cell that contains cilia for moving substances released from lung secretory cells.

NFIB

GO:0061145

BP

lung smooth muscle development

The process whose specific outcome is the progression of smooth muscle in the lung over time, from its formation to the mature structure.

SOX9

GO:0061149

BP

BMP signaling pathway involved in ureter morphogenesis

A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the shaping of the ureter. The ureter is a tube that extends from the kidney to the bladder.

BMP4

GO:0061151

BP

BMP signaling pathway involved in renal system segmentation

A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the segmentation of the renal system.

BMP4

GO:0061154

BP

endothelial tube morphogenesis

The process in which the anatomical structures of a tube are generated and organized from an endothelium. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.

CTNNB1, RHOB, CCM2, PRKD2

GO:0061155

BP

pulmonary artery endothelial tube morphogenesis

The process in which the anatomical structures of a tube are generated and organized from the pulmonary artery endothelium. An pulmonary artery endothelium is an epithelium that lines the pulmonary artery.

BMP4

GO:0061156

BP

pulmonary artery morphogenesis

The process in which the anatomical structures of the pulmonary artery are generated and organized. The pulmonary artery is the artery that carries blood from the heart to the lungs.

JAG1

GO:0061157

BP

mRNA destabilization

Any process that decreases the stability of an mRNA molecule, making it more vulnerable to degradative processes. Messenger RNA is the intermediate molecule between DNA and protein. It includes UTR and coding sequences. It does not contain introns.

HNRNPR, PUM1, MEX3D, METTL14

GO:0061158

BP

3'-UTR-mediated mRNA destabilization

An mRNA destabilization process in which one or more RNA-binding proteins associate with the 3'-untranslated region (UTR) of an mRNA.

ZC3H12D, ZFP36, ZFP36L2, ZFP36L1, HNRNPD, CPEB3, KHSRP, QKI

GO:0061162

BP

establishment of monopolar cell polarity

The specification and formation of monopolar intracellular organization or cell growth patterns. Monopolar cell organization is directional organization along an axis.

MAP1B, GBF1

GO:0061178

BP

regulation of insulin secretion involved in cellular response to glucose stimulus

Any process that modulates the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.

LRP5, NR1D1, EFNA5, EPHA5, CDK16, TIAM1, NR1H4, SYBU, NRXN1

GO:0061179

BP

negative regulation of insulin secretion involved in cellular response to glucose stimulus

Any process that decreases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.

HMGCR, UCP2, NDUFAF2, ENY2

GO:0061180

BP

mammary gland epithelium development

The process whose specific outcome is the progression of the mammary gland epithelium over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.

JAK2, WNT2, WNT3

GO:0061182

BP

negative regulation of chondrocyte development

Any process that decreases the rate, frequency, or extent of the process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.

FAM101A, FAM101B

GO:0061198

BP

fungiform papilla formation

The developmental process pertaining to the initial formation of a spongiform papilla from unspecified parts. The fungiform papilla is a mushroom-shaped papilla of the tongue.

CTNNB1, HDAC1, HDAC2

GO:0061290

BP

canonical Wnt signaling pathway involved in metanephric kidney development

The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes that contribute to the progression of the metanephric kidney over time. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.

LGR4

GO:0061298

BP

retina vasculature development in camera-type eye

The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.

PDGFRB, PDGFRA, ACVR2B, BMPR2, HIF1A

GO:0061299

BP

retina vasculature morphogenesis in camera-type eye

The process in which the vasculature of the retina is generated and organized.

NRP1, NDP, RHOJ, FZD4

GO:0061301

BP

cerebellum vasculature morphogenesis

The process in which the vasculature of the cerebellum is generated and organized.

FZD4

GO:0061302

BP

smooth muscle cell-matrix adhesion

The binding of a smooth muscle cell to the extracellular matrix via adhesion molecules.

VTN, DDR1

GO:0061303

BP

cornea development in camera-type eye

The progression of the cornea over time, from its formation to the mature structure. The cornea is the transparent structure that covers the anterior of the eye.

WNT2B, WNT6

GO:0061304

BP

retinal blood vessel morphogenesis

The process whose specific outcome is the progression of a blood vessel of the retina over time, from its formation to the mature structure.

LRP5, CYP1B1, FZD4

GO:0061308

BP

cardiac neural crest cell development involved in heart development

The process aimed at the progression of a cardiac neural crest cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell that contributes to the development of the heart.

MAPK3, MAPK1